TY - JOUR
T1 - Correction to
T2 - Photoactivatable Silencing Extracellular Vesicle (PASEV) Sensitizes Cancer Immunotherapy (Advanced Materials, (2022), 34, 35, 10.1002/adma.202204765)
AU - Lu, Mei
AU - Xing, Haonan
AU - Shao, Wanxuan
AU - Zhang, Tian
AU - Zhang, Mengjie
AU - Wang, Yongchao
AU - Li, Fangzhou
AU - Weng, Yuhua
AU - Zheng, Aiping
AU - Huang, Yuanyu
AU - Liang, Xing Jie
N1 - Publisher Copyright:
© 2025 Wiley-VCH GmbH.
PY - 2025/6/19
Y1 - 2025/6/19
N2 - Adv. Mater. 2022, 34, 2204765 DOI: 10.1002/adma.202204765 The H&E image of the PASsiNCEV L+ group in Figure 5f and the immunofluorescent images of HMGB1 in the PBS and PASsiNCEV L+ groups in Figure S19c (Supporting Information) were used in error. The authors identified the mistake, and the corrected Figures 5f and S19c (Supporting Information) are as follows: Figure 5f. Representative images for hematoxylin and eosin (H&E) staining, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and Ki67 assay of the excised tumors. Scale bar: 100 µm. Figure S19c. Immunofluorescence imaging and quantitative analysis of CRT exposure and HMGB1 release in the primary tumor tissues of CT26-Luc tumor-bearing mice. Blue, cell nuclei. Red, CRT (the upper rows), and HMGB1 (the lower rows). Scale bar, 100 µm. Statistical significance was performed by one-way ANOVA with a Tukey post hoc test. *p < 0.05, **p < 0.01, ****p < 0.0001. We apologize for the error. The correction does not affect the conclusion drawn from the paper.
AB - Adv. Mater. 2022, 34, 2204765 DOI: 10.1002/adma.202204765 The H&E image of the PASsiNCEV L+ group in Figure 5f and the immunofluorescent images of HMGB1 in the PBS and PASsiNCEV L+ groups in Figure S19c (Supporting Information) were used in error. The authors identified the mistake, and the corrected Figures 5f and S19c (Supporting Information) are as follows: Figure 5f. Representative images for hematoxylin and eosin (H&E) staining, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and Ki67 assay of the excised tumors. Scale bar: 100 µm. Figure S19c. Immunofluorescence imaging and quantitative analysis of CRT exposure and HMGB1 release in the primary tumor tissues of CT26-Luc tumor-bearing mice. Blue, cell nuclei. Red, CRT (the upper rows), and HMGB1 (the lower rows). Scale bar, 100 µm. Statistical significance was performed by one-way ANOVA with a Tukey post hoc test. *p < 0.05, **p < 0.01, ****p < 0.0001. We apologize for the error. The correction does not affect the conclusion drawn from the paper.
UR - http://www.scopus.com/pages/publications/105002058964
U2 - 10.1002/adma.202505455
DO - 10.1002/adma.202505455
M3 - Comment/debate
AN - SCOPUS:105002058964
SN - 0935-9648
VL - 37
JO - Advanced Materials
JF - Advanced Materials
IS - 24
M1 - 2505455
ER -